Discover the latest news from the Pulmonary Hypertension, including advocacy updates, research articles and event coverage.
The latest issue of Advances in Pulmonary Hypertension focuses on drug- and toxin-related PH, the PAH treatment algorithm, drug safety and meth-related PH.
News
A new survey seeks feedback from people with serious respiratory illnesses and their caregivers about unmet care and support needs.
News
PHA weighs in on proposed regulations about prior authorization, step therapy, medical research and Medicaid work requirements.
News
AnMed Medical Center found a creative way to help patients feel less scared and anxious about procedures and tests outside the PH clinic.
News
Awkwafina competes on "Who Wants To Be a Millionaire" to support the Pulmonary Hypertension Association in honor of her mother.
News
Download PHA’s updated guide for patients and families, offering trusted support and information at every stage of the PH journey.
News
The label references trial data that shows the drug as safe and effective for moderate to high-risk PAH.
Pulmovant is enrolling participants in its Phase 3 mosliciguat study after positive Phase 2 results.
The FDA will review United Therapeutic’s new drug application for Ralinepag, a once-daily pill to treat PAH.
